Your browser doesn't support javascript.
The lncRNAs involved in regulating the RIG-I signaling pathway.
Liu, Jing; Ji, Qinglu; Cheng, Feng; Chen, Dengwang; Geng, Tingting; Huang, Yueyue; Zhang, Jidong; He, Yuqi; Song, Tao.
  • Liu J; Department of Immunology, Zunyi Medical University, Zunyi, China.
  • Ji Q; School of Pharmacy, Zunyi Medical University, Zunyi, China.
  • Cheng F; Department of Immunology, Zunyi Medical University, Zunyi, China.
  • Chen D; Department of Immunology, Zunyi Medical University, Zunyi, China.
  • Geng T; Department of Immunology, Zunyi Medical University, Zunyi, China.
  • Huang Y; Department of Immunology, Zunyi Medical University, Zunyi, China.
  • Zhang J; Department of Immunology, Zunyi Medical University, Zunyi, China.
  • He Y; Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine, Zunyi Medical University, Zunyi, China.
  • Song T; Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi, China.
Front Cell Infect Microbiol ; 12: 1041682, 2022.
Article in English | MEDLINE | ID: covidwho-2141716
ABSTRACT
Understanding the targets and interactions of long non-coding RNAs (lncRNAs) related to the retinoic acid-inducible gene-I (RIG-I) signaling pathway is essential for developing interventions, which would enable directing the host inflammatory response regulation toward protective immunity. In the RIG-I signaling pathway, lncRNAs are involved in the important processes of ubiquitination, phosphorylation, and glycolysis, thus promoting the transport of the interferon regulatory factors 3 and 7 (IRF3 and IRF7) and the nuclear factor kappa B (NF-κB) into the nucleus, and activating recruitment of type I interferons (IFN-I) and inflammatory factors to the antiviral action site. In addition, the RIG-I signaling pathway has recently been reported to contain the targets of coronavirus disease-19 (COVID-19)-related lncRNAs. The molecules in the RIG-I signaling pathway are directly regulated by the lncRNA-microRNAs (miRNAs)-messenger RNA (mRNA) axis. Therefore, targeting this axis has become a novel strategy for the diagnosis and treatment of cancer. In this paper, the studies on the regulation of the RIG-I signaling pathway by lncRNAs during viral infections and cancer are comprehensively analyzed. The aim is to provide a solid foundation of information for conducting further detailed studies on lncRNAs and RIG-I in the future and also contribute to clinical drug development.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / RNA, Long Noncoding / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.1041682

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / RNA, Long Noncoding / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Cell Infect Microbiol Year: 2022 Document Type: Article Affiliation country: Fcimb.2022.1041682